Virtu Financial’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-39,647
Closed -$58K 1989
2024
Q4
$58K Buy
+39,647
New +$58K ﹤0.01% 1137
2024
Q3
Sell
-4,086
Closed -$31K 1853
2024
Q2
$31K Buy
4,086
+2,731
+202% +$20.7K ﹤0.01% 975
2024
Q1
$20K Buy
+1,355
New +$20K ﹤0.01% 1167
2023
Q3
Sell
-492
Closed -$42K 1856
2023
Q2
$42K Buy
+492
New +$42K ﹤0.01% 1165
2022
Q4
Sell
-153
Closed -$40K 2098
2022
Q3
$40K Buy
+153
New +$40K ﹤0.01% 1249
2022
Q2
Sell
-46
Closed -$42K 2034
2022
Q1
$42K Sell
46
-58
-56% -$53K ﹤0.01% 1175
2021
Q4
$106K Buy
+104
New +$106K 0.01% 1114
2021
Q2
Sell
-26
Closed -$146K 2039
2021
Q1
$146K Buy
+26
New +$146K 0.01% 1192
2019
Q1
Hold
0
-$15K 1791
2018
Q4
Hold
0
1397
2018
Q3
Hold
0
-$33K 2124
2018
Q2
Hold
0
1814